Biodegradable microspherical implants containing teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis

Archives of Orthopaedic and Trauma Surgery

Volumn 130, Issue 1, 2010, Pages 135-142

  Orhan, Zafer ^a   Cevher, Erdal ^b   Yıldız, Ayca ^b   Ahıskalı, Rengin ^c   Sensoy, Demet ^b   Mülazımoğlu, Lütfiye ^c  

^a DUZCE UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c MARMARA UNIVERSITY   (Turkey)

Author keywords

MRSA; Osteomyelitis; TCP PLGA implants

Indexed keywords

MICROSPHERE; POLYGLACTIN; TEICOPLANIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADATION; CHRONIC OSTEOMYELITIS; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; EMULSION; ENCAPSULATION; HISTOPATHOLOGY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; THERMAL ANALYSIS; TIBIA;

ABSORBABLE IMPLANTS; ANALYSIS OF VARIANCE; ANIMALS; ANTI-BACTERIAL AGENTS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; LACTIC ACID; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROSPHERES; OSTEOMYELITIS; PARTICLE SIZE; POLYGLYCOLIC ACID; RATS; RATS, WISTAR; STAPHYLOCOCCAL INFECTIONS; TIBIA;

EID: 71449125742     PISSN: 09368051     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00402-009-0886-9     Document Type: Article

References (37)

1. DP Lew FA Waldvogel 2004 Osteomyelitis Lancet 364 369 379 10.1016/S0140-6736(04)16727-5 10.1016/S0140-6736(04)16727-5 1:CAS:528: DC%2BD2cXmtVSktbc%3D 15276398 (Pubitemid 38976521)
2. I Yenice S Calis B Atilla, et al. 2003 In vitro/in vivo evaluation of the efficiency of teicoplanin-loaded biodegradable microparticles formulated for implantation to infected bone defects J Microencapsul 20 705 717 10.1080/0265204031000154179 10.1080/0265204031000154179 1:CAS:528: DC%2BD3sXptVOntbg%3D 14594660 (Pubitemid 37406794)
3. EL Compere WI Metzger RN Mitra 1972 The treatment of pyogenic bone and joint infections by closed irrigation (circulation) with a non-toxic detergent and one or more antibiotics J Bone Joint Surg Am 54-A 1227 1234
4. D Mackey A Varlet D Debeaumont 1982 Antibiotic loaded plaster of Paris pellets: an in vitro study of a possible method of local antibiotic therapy in bone infection Clin Orthop Relat Res 167 263 268 7094471
5. K Adams L Couch G Cierny, et al. 1992 In vitro and in vivo evaluation of antibiotic diffusion from antibiotic-impregnated polymethacrylate beads Clin Orthop Relat Res 278 244 252 1563160
6. K Kawanabe Y Okada Y Matsusue, et al. 1998 Treatment of osteomyelitis with antibiotic-soaked porous glass ceramic J Bone Joint Surg Br 80 527 530 10.1302/0301-620X.80B3.8576 10.1302/0301-620X.80B3.8576 1:STN:280: DyaK1c3otFamsg%3D%3D 9619951 (Pubitemid 28230591)
7. V Mendel HJ Simanovski HC Scholz, et al. 2005 Therapy with gentamycin-PMMA beads, gentamycin-collagen sponge, and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats Arch Orthop Trauma Surg 125 363 368 10.1007/s00402-004-0774-2 10.1007/s00402-004-0774-2 1:STN:280:DC%2BD2MznsFKksw%3D%3D 15864679 (Pubitemid 41102406)
8. E Cevher Z Orhan L MülazImoǧlu, et al. 2006 Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres Int J Pharm 317 127 135 10.1016/j.ijpharm.2006.03. 014 10.1016/j.ijpharm.2006.03.014 1:CAS:528:DC%2BD28Xmt1ajtrs%3D 16624509 (Pubitemid 43914289)
9. Z Orhan E Cevher L MülazImoǧlu, et al. 2006 The preparation of ciprofloxacin hydrochloride-loaded chitosan and pectin microspheres: their evaluation in an animal osteomyelitis model J Bone Joint Surg Br 88 270 275 10.1302/0301-620X.88B2.16328 10.1302/0301-620X.88B2.16328 1:STN:280: DC%2BD28%2FksFyhug%3D%3D 16434537 (Pubitemid 43279944)
10. C Teupe R Meffert S Wincler, et al. 1992 Ciprofloxacin- impregnated poly-L-Lactic acid drug carrier: new aspects of a resorbable drug delivery system in local antimicrobial treatment of bone infections Arch Orthop Trauma Surg 112 33 35 10.1007/BF00431041 10.1007/BF00431041 1:STN:280: DyaK3s7ivFGisw%3D%3D 1482616 (Pubitemid 23027883)
11. M Ramchandani D Robinson 1998 In vitro and in vivo release of ciprofloxacin from PLGA 50-50 implants J Control Release 54 167 175 10.1016/S0168-3659(97)00113-2 10.1016/S0168-3659(97)00113-2 1:STN:280: DyaK1czpt1Witw%3D%3D 9724903 (Pubitemid 28342695)
12. RN Brogden DH Peters 1994 Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy Drugs 47 823 854 10.2165/00003495-199447050-00008 10.2165/00003495-199447050-00008 1:CAS:528:DyaK2cXlsVyisLo%3D 7520860
13. DM Campoli-Richards RN Brogden D Faulds 1990 Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential Drugs 40 449 486 10.2165/00003495-199040030-00007 10.2165/00003495-199040030- 00007 1:CAS:528:DyaK3MXlsFSquw%3D%3D 2146108
14. APR Wilson B Taylor T Treasure, et al. 1998 Antibiotic prophylaxis in cardiac surgery: serum and tissue levels of teicoplanin, flucloxacillin and tobramycin J Antimicrob Chemother 21 201 212 10.1093/jac/21.2.201 10.1093/jac/21.2.201
15. JL Le Frock AM Ristuccia the Teicoplanin Bone, Joint Cooperative Study Group 1999 Teicoplanin in the treatment of bone and joint infections: an open study J Infect Chemother 5 32 39 10.1007/s101560050005 10.1007/s101560050005 1:CAS:528:DyaK1MXislKiu7k%3D (Pubitemid 29197266)
16. S Benita JP Benoit F Puisieux, et al. 1984 Characterisation of drug loaded poly (D, L-lactide) microspheres J Pharm Sci 73 1721 1724 10.1002/jps.2600731215 10.1002/jps.2600731215 1:CAS:528:DyaL2MXhtlOlt7s%3D 6527243 (Pubitemid 15190922)
17. E Riva N Ferry A Cometti, et al. 1987 Determination of teicoplanin in human plasma and urine by affinity and reversed-phase high-performance liquid chromatography J Chromatogr A 421 99 110 10.1016/0378-4347(87)80383-3 10.1016/0378-4347(87)80383-3 1:CAS:528:DyaL1cXhtVA%3D (Pubitemid 17147284)
18. Council Directive 86/609/EEC (1986) European Convention for the protection of vertebrate animals used for experimental and other scientific purposes. Off J C Eur Comm L 358:1-48
19. Chapter 71, Sterility Tests, The United State Pharmacopeia/The National Formulary, USP30/NF25, Vol. 1 (2007) The United State pharmacopeial convention, Rockville, pp 97-102
20. CW Norden 1970 Experimental osteomyelitis. I: a description of the model J Infect Dis 122 410 418 1:STN:280:DyaE3M%2Fis1agtA%3D%3D 5476391
21. O'Reilly T, Mader JT (1999) Rat model of bacterial osteomyelitis of the tibia. In: Zak O, Sande MA (eds) Handbook of animal models of infection: experimental model in antimicrobial chemotherapy. Academic Press, San Diego, pp 560-575
22. JP Rissing 1990 Animal models of osteomyelitis. Knowledge, hypothesis, and speculation Infect Dis Clin North Am 4 377 390 1:STN:280: DyaK3M%2FhtVKisw%3D%3D 2212595
23. E Cevher Z Orhan D Sensoy, et al. 2007 Sodium fusidate-poly(D, L-lactide-co-glycolide) microspheres: preparation, characterization and in vivo evaluation of their effectiveness in the treatment of chronic osteomyelitis J Microencapsul 24 577 595 10.1080/02652040701472584 10.1080/02652040701472584 1:CAS:528:DC%2BD2sXotVOjtL8%3D 17654177 (Pubitemid 47180540)
24. J Lazarettos N Efstathopoulos PJ Papagelopoulos, et al. 2004 A bioresorbable calcium phosphate delivery system with teicoplanin for treating MRSA osteomyelitis Clin Orthop Relat Res 423 253 258 10.1097/01.blo.0000127422. 06956.35 10.1097/01.blo.0000127422.06956.35 15232458
25. G Wang SJ Liu SWN Ueng EC Chan 2004 The release of cefazoline and gentamicin from biodegradable PLA/PGA beads Int J Pharm 273 203 212 10.1016/j.ijpharm.2004.01.010 10.1016/j.ijpharm.2004.01.010 1:CAS:528: DC%2BD2cXhvVGqtro%3D 15010144 (Pubitemid 38317053)
26. N Rushton 1997 Applications of local antibiotic therapy Eur J Surg 578 27 30
27. I Gürsel F Korkusuz F Türesin, et al. 2001 In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis Biomaterials 22 73 80 10.1016/S0142-9612(00)00170- 8 10.1016/S0142-9612(00)00170-8 11085386 (Pubitemid 30734453)
28. GJ Popham P Mangino D Seligson, et al. 1991 Antibiotic impregnated beads. Part II. Factors in antibiotic selection Orthop Rev 20 331 337 1:STN:280:DyaK3M3lt1SqsA%3D%3D 2041655
29. SL Henry KP Galloway 1995 Local antibiotic therapy for the management of orthopaedic infections. Pharmacokinetic considerations Clin Pharmacokinet 29 36 45 10.2165/00003088-199529010-00005 10.2165/00003088-199529010-00005 1:STN:280:DyaK28%2FmsFygsw%3D%3D 7586897
30. GH Walenkamp 2001 Gentamicin PMMA beads and other local antibiotic carriers in two-stage revision of total knee infection: a review J Chemother 13 Spec No 1 1 66 72
31. G Schaison W Graninger E Bouza 2000 Teicoplanin in the treatment of serious infection J Chemother 12 suppl 5 26 33 11131961
32. C Castro C Evora M Baro, et al. 2005 Two-month ciprofloxacin implants for multibacterial bone infections Eur J Pharm Biopharm 60 401 406 10.1016/j.ejpb.2005.02.005 10.1016/j.ejpb.2005.02.005 1:CAS:528: DC%2BD2MXlvFarsL8%3D 15996581 (Pubitemid 40922837)
33. JM Karp MS Shoichet JE Davies 2003 Bone formation on two-dimensional poly(D, L-lactide-co-glycolide) (PLGA) films and three-dimensional PLGA tissue engineering scaffolds in vitro J Biomed Mater Res A 64 388 396 10.1002/jbm.a.10420 10.1002/jbm.a.10420 12522827
34. R Ghiselli O Cirioni A Giacometti, et al. 2008 Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections J Surg Res 144 74 81 10.1016/j.jss.2007.02.051 10.1016/j.jss.2007.02.051 1:CAS:528:DC%2BD2sXhsVent7jN 17574587 (Pubitemid 350234955)
35. F Ismael R Bléton A Saleh-Mghir, et al. 2003 Teicoplanin- containing cement spacers for treatment of experimental Staphylococcus aureus joint prosthesis infection Antimicrob Agents Chemother 47 3365 3367 10.1128/AAC.47.10.3365-3367.2003 10.1128/AAC.47.10.3365-3367.2003 1:CAS:528:DC%2BD3sXnvVWmtbs%3D 14506060 (Pubitemid 37229608)
36. A Fernández C Cabellos F Tubau, et al. 2005 Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis J Antimicrob Chemother 55 78 83 10.1093/jac/dkh496 10.1093/jac/dkh496 15546968 (Pubitemid 40192617)
37. Griffith D, Dudley DM (2007) Animal models of infection for the study of antibiotic pharmacodynamics. In: Nightingale CH, Ambrose PG, Drusano GL, Murakawo T (eds) Antimicrobial pharmacodynamics in theory and clinical practice. Informa Healthcare USA Inc, New York, pp 78-102